KidneyTumors for II year MBBS students.ppt

CsbrPrasad1 23 views 72 slides Sep 25, 2024
Slide 1
Slide 1 of 72
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53
Slide 54
54
Slide 55
55
Slide 56
56
Slide 57
57
Slide 58
58
Slide 59
59
Slide 60
60
Slide 61
61
Slide 62
62
Slide 63
63
Slide 64
64
Slide 65
65
Slide 66
66
Slide 67
67
Slide 68
68
Slide 69
69
Slide 70
70
Slide 71
71
Slide 72
72

About This Presentation

Target audience: For II year MBBS students


Slide Content

Kidney TumorsKidney Tumors
Dr.CSBR.Prasad, MD., MNAMS.,
Aug-2024-CSBRP

Malignant TumorsMalignant Tumors
Aug-2024-CSBRP

Wilms’ tumorWilms’ tumor
[[Nephroblastoma]]
•Malignant tumor of embryonic nephrogenic
elements
•Composed of: 3 components
1.Blastema
2.Stromal elements
3.Epithelial elements
•Most common abdominal solid tumor in
children [1:10,000]
•80% of all pediatric neoplasms
Aug-2024-CSBRP

Wilms’ tumorWilms’ tumor
[[Nephroblastoma]]
PathogenesisPathogenesis:
Defects in WT1 gene (chr# 11)
•Protein is a transcription factors that regulates the
expression of genes Eg: IGF1, PDGF
Defect in WTX on X-chromosome
Associated with THREE congenital syndromes:
1.WAGR syndrome (PAX & WT1, rarely WT2)
2.Denys-Drash Syndrome (Intersex, mesangeal
sclerosis)
3.Beckwith-Weidmann syndrome (WT2)
Aug-2024-CSBRP

Wilms’ tumorWilms’ tumor
[[Nephroblastoma]]
PathologyPathology:
•Gross:
–Large
–Capsulated
–Bulging, grey white cut surface
•Histology: Three elements in varying proportions
1.Blastemal cells – small blue cells, arranged in trabaculae &
nests
2.Epitheial elements: Tubules, glomeruloid strucutes
3.Stromal elements: Smooth muscle, skeletal muscle and
fibroblasts
Aug-2024-CSBRP

Wilms’ tumorWilms’ tumor
[[Nephroblastoma]]
Clinical featuresClinical features:
•Between 1-3 years
•Abdominal mass
•Abdominal pain
•Hypertension
•Hematuria
Aug-2024-CSBRP

Aug-2024-CSBRP

Aug-2024-CSBRP

Aug-2024-CSBRP

Aug-2024-CSBRP

Aug-2024-CSBRP

Aug-2024-CSBRP

Aug-2024-CSBRP

Syndromes associated with Wilms’
Denys–Drash syndrome
Aug-2024-CSBRP

Syndromes associated with Wilms’
WAGR syndrome
Aug-2024-CSBRP
Wilms’ tumor
Aniridia
Gonadoblastoma
Retardation

Syndromes associated with Wilms’
Beckwith–Wiedemann syndrome
Aug-2024-CSBRP

Wilms’ tumorWilms’ tumor
[[Nephroblastoma]]
PrognosisPrognosis:
•Good <2years of age
•Surgery, radiation and chemo forms
mainstay of therapy
•Long term survival >90%
Aug-2024-CSBRP

Renal Cell CarcinomaRenal Cell Carcinoma
Aug-2024-CSBRP

Renal Cell CarcinomaRenal Cell Carcinoma
•Malignant tumor of renal tubular cells
•Variety:
–Sporadic (most common)
–Hereditary (5%, bilateral, young age)
•Associated with THREE syndromes:
1.von Hipple-Lindau syndrome
2.AD RCC
3.Hereditary papillary RCC (inherited)
•Smoking
Aug-2024-CSBRP

von Hippel–Lindau disease
•Angiomatosis
•Hemangioblastoma
•Pheochromocytoma
•Papillary cystadenoma of epidydimis /
broad ligament
•Endolymphatic sac tumor
•RCC
Aug-2024-CSBRP

Renal cell
carcinoma
Aug-2024-CSBRP

Renal cell carcinomaRenal cell carcinoma
Aug-2024-CSBRP

Renal cell carcinoma - Renal cell carcinoma - Clear cell type
Aug-2024-CSBRP

Aug-2024-CSBRP
Renal cell carcinoma - Renal cell carcinoma - Clear cell type

RCC- Chromophobe typeRCC- Chromophobe type
•3rd most common subtype of RCC
•Morphological types:
1.“Classic" and
2.Eosinophilic types
•overlaps with oncocytoma and often poses a
diagnostic problem
•Cytogenetics: multiple chromosomal
losses involving 1, 6, 10, 13, 17, 21 and Y
(more than in oncocytoma)
Aug-2024-CSBRP

RCC- Chromophobe typeRCC- Chromophobe type
Gross:
–Well-circumscribed,
solid, beige or light
brown 
–Eosinophilic type can
be mahogany-brown
and ~1/5 has central
scar (similar to
oncocytoma)
Aug-2024-CSBRP

RCC- Chromophobe typeRCC- Chromophobe type
Aug-2024-CSBRP

RCC- Chromophobe typeRCC- Chromophobe type
Aug-2024-CSBRP

RCC- Chromophobe typeRCC- Chromophobe type
Colloidal iron stain
Aug-2024-CSBRP

RCC- Chromophobe typeRCC- Chromophobe type
Chromophobe is less common than
papillary, is indolent, is less aggressive, and
it progresses more slowly than the other
But, when it is metastatic, it is incurable
Aug-2024-CSBRP

RCC- Chromophobe typeRCC- Chromophobe type
•Inherited syndrome associated with
Chromophobe-RCC is Birt-Hogg-Dube
syndrome
•Mutation in BHD genes
Aug-2024-CSBRP

Birt–Hogg–Dubé syndrome
Aug-2024-CSBRP

Papillary – Type-1 RCCPapillary – Type-1 RCC
•Inherited syndrome:
–Germ line mutation of c-met gene
–Constitutive activation of c-met receptor
•In sporadic tumors: 10-15% c-met
mutation
Aug-2024-CSBRP

Papillary – Type-1 RCCPapillary – Type-1 RCC
Aug-2024-CSBRP

Aug-2024-CSBRP

Aug-2024-CSBRP

Papillary renal cell carcinoma
psammoma bodies
Aug-2024-CSBRP

Papillary – Type-2 RCCPapillary – Type-2 RCC
•Inherited syndrome:
–Germ line mutation of tumor suppressor gene
- Fumarate hydratase gene (HLRCC)
–Constitutive activation of c-met receptor
•In sporadic tumors:
–Not well characterized
Aug-2024-CSBRP

Papillary – Type-2 RCCPapillary – Type-2 RCC
Aug-2024-CSBRP

Collecting Duct carcinomaCollecting Duct carcinoma
[Bellini duct carcinoma]
•Aggressive epithelial malignancy of renal medulla
•Rare: <1% of adult renal epithelial tumors, controversial
– often a diagnosis of exclusion
•2/3 male, mean age 55 years, associated with analgesic
nephropathy 
•Origin: likely from distal collecting (Bellini’s) ducts
•Histology: Mixed features of RCC + TCC
Marked tumor desmoplasia
•Behavior: Like TCC
•Invariably presents at an advanced state
Aug-2024-CSBRP

Collecting Duct carcinomaCollecting Duct carcinoma
Gross:
•Infiltrative, firm, gray-white, mean 5 cm
•Originates in medulla (as do some clear cell
carcinomas)
•May have intrarenal metastases; usually no
hemorrhage
Aug-2024-CSBRP

Collecting Duct carcinomaCollecting Duct carcinoma
•Histology: Shows irregular tubules, high-grade hobnail cells
and marked desmoplasia
•Infiltrative borders
•Major criteria: involvement of medullary pyramid (small
tumors), irregular tubular architecture, marked
desmoplasia, high grade hobnail cells, positive for high
molecular weight cytokeratin and Ulex europaeus, no
urothelial carcinoma elsewhere
•Minor criteria: central location (large tumors), papillary
architecture with wide fibrous stalks and desmoplastic
stroma, inflammatory stroma with neutrophils; extensive
renal, extrarenal and vascular infiltration, mucin positive
Aug-2024-CSBRP

Collecting Duct carcinomaCollecting Duct carcinoma
Aug-2024-CSBRP

Collecting Duct carcinomaCollecting Duct carcinoma
Aug-2024-CSBRP

Collecting Duct carcinomaCollecting Duct carcinoma
Aug-2024-CSBRP

Renal medullary RCCRenal medullary RCC
•Renal medullary RCC is very closely
associated with collecting duct, and affects
young African Americans with Sickle cell
trait and sickle cell disease
Aug-2024-CSBRP

Renal medullary RCCRenal medullary RCC
Aug-2024-CSBRP

Aug-2024-CSBRP

Aug-2024-CSBRP

Renal tumors associated with
Sickle cell trait / disease
•Renal medullary RCC
•ALK positive RCC
Aug-2024-CSBRP

Sarcomatoid RCCSarcomatoid RCC
•It is associated with both clear cell and
non-clear cell RCC histologies
•Prognosis is relatively poor
Aug-2024-CSBRP

Sarcomatoid renal cell carcinoma. The tumor is infiltrative with
extensive necrosis; the sarcomatoid component is indicated by the
fleshy gray-white areas (top left part of the tumor).
Aug-2024-CSBRP

RCC - Sarcomatoid carcinomaRCC - Sarcomatoid carcinoma
Aug-2024-CSBRP

Chromophobe renal cell carcinoma with
sarcomatoid differentiation
Aug-2024-CSBRP

RCC - Sarcomatoid carcinomaRCC - Sarcomatoid carcinoma
Aug-2024-CSBRP

Aug-2024-CSBRP

Points regarding “Bone
mets”
BK.Patil
•Osteosclerotic mets: Prostate, Breast,
Carcinoid
•Osteolytic mets: Most of the other mets are
osteolytic
Aug-2024-CSBRP

Points regarding “Bone
mets”
Bone seeking kidney tumor
“Clear cell sarcoma of kidney”
Aug-2024-CSBRP

Chest CT scan, an abdominal CT that shows a large kidney mass,
and a bone scan with widespread metastasis
Aug-2024-CSBRP

Acute LEFT
varicocele
"bag of worms"
surrounding the
testis
Think of RCC of left
kidney
Aug-2024-CSBRP

Mechanism of Acute left
varicocele in RCC
Left testicular vein
drains into left renal
vein; Where as right
testicular vein joins
IVC
RCC has propensity to
invade into veins and
may grow as a column
upto the right side of
the heartAug-2024-CSBRP

Name some childhood tumors?
Add ‘BLASTOMA’ to the tissue
•Medulloblastoma
•Retinoblastoma
•Nephroblastoma
•Hepatoblastoma
Aug-2024-CSBRP
Avoid:
Pulmonary blastoma
Osteoblastoma
Chondroblastoma

Summary
Two renal tumors of importance are:
Renal cell carcinoma
•Adults
•Presents with silent
hematuria
•Gross:
–Circumscribed, bright
yellow tumor
–One pole of the kidney
•Histology:
–Clear cells
–Rich vascularity
•Variants: Clear cell,
Chromophobe, Papillary,
Sarcomtoid, Medullary
•Chromophobe has got good
prognosis
•Sarcomatoid carcinoma has
got worst prognosis
•Spread by Hematogenous
route
•Bone mets are common
–Pulsatile mets
Aug-2024-CSBRP

Summary
Two renal tumors of importance are:
Wilms’ tumor
•Children
•Present with abdominal
swelling, pain and hematuria
•Histology: Blastemal cells,
epithelial tubules and
mesenchymal cells
•Syndromes: WAGR, Denys-
Drash, Beckwith-
Wiedemann
•WT gene mutation
•Good prognosis:
–<2yrs of age
•Surgery, chemoradiation
is the main stay of Tx
Aug-2024-CSBRP

Questions
1.“Silent hematuria” is a feature, of which
kidney tumor?
2.Acute left sided varicocele should rise the
suspicion of …..?
3.Name the type of RCC seen in sickle cell trait
/ anemia ?
4.Name some bone metastasizing tumors?
5.Name the three syndromes associated with
Wilms’ tumor?
Aug-2024-CSBRP

E N D
Aug-2024-CSBRP

Name the syndrome?
Aug-2024-CSBRP

Aug-2024-CSBRP
Testicular tumor
Name the syndrome?

Aug-2024-CSBRP
Name the
syndrome?

Identify the syndrome
Aug-2024-CSBRP

Identify this kidney tumorIdentify this kidney tumor
Aug-2024-CSBRP

What this patient may be
suffering from?
Aug-2024-CSBRP